Lifting Lockdowns During Pandemic In Africa May Prevent Deaths From Other Causes 11/06/2020 Grace Ren African countries are lifting lockdowns even as COVID-19 cases across the continent reached a grim new milestone, topping 200,000 cases. The pandemic took only 19 days to reach 200,000 cases in Africa, while it took 98 days to reach the first 100,000 cases. Yet carefully easing lockdown orders in Africa may be the right move […] Continue reading -> COVID-19 Food Insecurity: An Additional 135 Million People Worldwide Will Be Undernourished 14/05/2020 Tsering Lhamo An additional 135 million people globally will be unable to feed themselves if measures are not put in place to ensure food security, said World Food Programme Regional Director for West and Central Africa Chris Nikoi, in a regular press briefing on Thursday. In the WHO African region, an extra 22 million people will be […] Continue reading -> Life Expectancy Increased, But COVID-19 Threatens Gains 13/05/2020 Grace Ren Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Food Insecurity: An Additional 135 Million People Worldwide Will Be Undernourished 14/05/2020 Tsering Lhamo An additional 135 million people globally will be unable to feed themselves if measures are not put in place to ensure food security, said World Food Programme Regional Director for West and Central Africa Chris Nikoi, in a regular press briefing on Thursday. In the WHO African region, an extra 22 million people will be […] Continue reading -> Life Expectancy Increased, But COVID-19 Threatens Gains 13/05/2020 Grace Ren Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
Life Expectancy Increased, But COVID-19 Threatens Gains 13/05/2020 Grace Ren Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts
New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Posts navigation Older postsNewer posts